FDA 510(k)

IntelliWave3，矽膠水凝式日戴軟性隐形眼镜（efrofilcon A）

K 號：K230824 · 2023-09-06

決定日期2023-09-06

產品代碼LPL

諮詢委員會此為醫療器材法規文本之翻譯。根據醫療法規翻譯政策，以下為繁體中文譯文：本文件概述適用於醫療器材之監管架構，包括美國食品藥物管理局（FDA）之上市前審查程序。第510(k)條途徑適用於與已合法上市器材（predicate device）實質等效之器材，而上市前核准（PMA）則為最高風險等級（Class III）器材所要求。臨床證據可能引用NCT編號之試驗登記，或PMID編號之同行評審文獻。所有產品名稱、公司名稱、識別碼及統一資源定位符（URL）均保留原文，以確保可追溯性及法規提交之完整性。

決定相當於

器材摘要

IntelliWave3, Silicone Hydrogel Daily Wear Soft Contact Lens (efrofilcon A) is the device name listed in this FDA 510(k) record. The listed applicant is Art Optical Contact Lens, Inc.. It received FDA 510(k) clearance on 2023-09-06 under 510(k) number K230824. The device is classified under product code LPL. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the IntelliWave3, Silicone Hydrogel Daily Wear Soft Contact Lens (efrofilcon A)?

IntelliWave3, Silicone Hydrogel Daily Wear Soft Contact Lens (efrofilcon A) is a medical device that received FDA 510(k) clearance on 2023-09-06. The listed applicant is Art Optical Contact Lens, Inc.. The 510(k) number is K230824.

When did IntelliWave3, Silicone Hydrogel Daily Wear Soft Contact Lens (efrofilcon A) receive FDA 510(k) clearance?

IntelliWave3, Silicone Hydrogel Daily Wear Soft Contact Lens (efrofilcon A) received FDA 510(k) clearance on 2023-09-06, under 510(k) number K230824.

Who is the listed applicant for IntelliWave3, Silicone Hydrogel Daily Wear Soft Contact Lens (efrofilcon A)?

The FDA 510(k) record lists Art Optical Contact Lens, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for IntelliWave3, Silicone Hydrogel Daily Wear Soft Contact Lens (efrofilcon A)?

The FDA product code for IntelliWave3, Silicone Hydrogel Daily Wear Soft Contact Lens (efrofilcon A) is LPL.

其他以 Art Optical Contact Lens, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K172314Ampleye 角膜 RGP 間質鏡 (roflufocon D, roflufocon E, hexafocon A, paflufocon D)

相關器械（代碼：LPL）

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。